BioSpace News Archive

BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory and degenerative diseases through a portfolio built around gelsolin technology, announced today that recent publications of independent studies have reported that low levels of gelsolin are associated with severe illness and organ failure in COVID-19 patients

Financial executives at wealth management advisory Oita Chuo Pacific Management have commented on Sanofi S.A. agreeing to acquire U.S. biotech firm Principia Biopharma Inc. in a deal worth $3.4 billion, as the French drug manufacturer shifts towards innovative treatments to boost growth under latest Chief Executive Officer Paul Hudson. According to data collected by Oita Chuo Pacific Management , the all-cash-deal will see

The Biocodex Microbiota Foundation is looking for academics and scientists in Canada to apply for a €25,000 research grant aimed at helping advance the study of the gut microbiome

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first in Illinois to use a new advanced imaging system during cryoablation, a minimally-invasive treatment for atrial fibrillation requiring precise images of the heart.

Aerolase Inc. is proud to announce its debut on the iconic Inc. 5000 list of America’s fastest-growing private companies as measured by revenues. In the just-released list for this year, it is solidly in the top half, at #2020 in the rankings.

A “Swiss army knife” protein that is active against several viruses may also offer some protection against Nipah virus, a lethal pathogen with no cure or vaccine.

On August 26 2020, Claigan Environmental Inc. will present a webinar on common practices to manage the nanomaterials requirements of the EU Medical Device Regulation.

Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator.

Sanara MedTech Inc. (“Sanara” or the “Company”) (OTCQB:SMTI), a provider of wound and skin care products and solutions dedicated to improving patient outcomes, announced today an expansion of its comprehensive wound and skin care strategy.